New York, NY — Bruker Optics and Patterson-Kelley announces partnership for dedicated Pharmaceuticual Manufacturing solutions.
United States Food and Drug Administration now has more emphasize on the PAT Initiative which requires pharmaceutical companies to ensure the quality of all materials by applying real-time analytical testing during process. Bruker Optics and Patterson Kelley are committed to the development and support of leading-edge technology for the FDA Process Analytical Technologies (PAT) initiative.
Bruker Optics’ dedicated process spectrometers can be mounted on Patterson-Kelley V-blenders and pharmaceutical dryers, to enable real-time measurements for quality control.
Dan Klevisha, Vice President of Sales and Marketing for Bruker Optics announced, “I’m very plased with the finalization of our partnership. We are expecting to bring a technology know-how and complete PAT solution to our key pharmaceutical manufacturing customers. As Bruker Optics, we are constantly improving our Fourier Transform and dispersive analytical instruments, developing new technologies to bring dedicated solutions for pharmaceutical industry. For example, our new non-contact LANCER NIR analyzer can be mounted onto a Patterson-Kelley blending equipment to wirelessly transmit ‘PAT feedback’ on the content uniformity, blending uniformity, moisture and other important process criterias.”
Jef Potters, Sales Manager for Patterson-Kelley stated: “Providing engineered solutions to the Pharmaceutical industry is the mission of Patterson-Kelley. P-K is Process Knowledge. The implementation of Process Analytical Technologies for P-K goes beyond Quality Control. It is our intention to use PAT as an integral part of Process Control. Bruker Optics provides the best NIR solutions and is the ideal partner for P-K”.